Cargando…
Development and validation of a TP53-associated immune prognostic model for hepatocellular carcinoma
BACKGROUND: TP53 mutation is the most common mutation in hepatocellular carcinoma (HCC), and it affects the progression and prognosis of HCC. We investigated how TP53 mutation regulates the HCC immunophenotype and thus affects the prognosis of HCC. METHODS: We investigated TP53 mutation status and R...
Autores principales: | Long, Junyu, Wang, Anqiang, Bai, Yi, Lin, Jianzhen, Yang, Xu, Wang, Dongxu, Yang, Xiaobo, Jiang, Yan, Zhao, Haitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491941/ https://www.ncbi.nlm.nih.gov/pubmed/30885723 http://dx.doi.org/10.1016/j.ebiom.2019.03.022 |
Ejemplares similares
-
Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019) -
DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019) -
Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials
por: Wang, Dongxu, et al.
Publicado: (2020) -
Construction and Validation of a Reliable Six-Gene Prognostic Signature Based on the TP53 Alteration for Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021) -
The diagnostic and prognostic role of RhoA in hepatocellular carcinoma
por: Bai, Yi, et al.
Publicado: (2019)